EZY-1 inhibits idiopathic pulmonary fibrosis by regulating M2-type macrophage differentiation

EZY-1 inhibits idiopathic pulmonary fibrosis by regulating M2-type macrophage differentiation

Macrophage differentiation is closely associated with idiopathic pulmonary fibrosis (IPF) initiation. Herein, we show that EZY-1, a novel peptide derived from Eucheuma, regulates macrophage differentiation to inhibit IPF. Macrophage differentiation was detected by analyzing the surface antigens of t...

Full description

Bibliographic Details
Main Authors:	Jun Wu, Mingjin Tu, Ting Wei, Xiaoqin Huang, Jianming Chen, Yufang Jia, Liuyan He, Xilian Tang, Huajun Yu, Haitao Zhang
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Journal of Functional Foods
Subjects:	Idiopathic pulmonary fibrosis EZY-1 Macrophages Fibroblasts
Online Access:	http://www.sciencedirect.com/science/article/pii/S1756464623005480

Similar Items

Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk
by: Zeng C, et al.
Published: (2024-02-01)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01)

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
by: Ana eCamelo, et al.
Published: (2014-01-01)

A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes
by: Yu Bao, et al.
Published: (2024-04-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Circular RNAs and their roles in idiopathic pulmonary fibrosis
by: Akshaya Surendran, et al.
Published: (2024-02-01)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Yahan Xu, et al.
Published: (2023-11-01)

Plasticity towards Rigidity: A Macrophage Conundrum in Pulmonary Fibrosis
by: Ezgi Sari, et al.
Published: (2022-09-01)

Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
by: Måns Kadefors, et al.
Published: (2022-08-01)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
by: Shanshan Liu, et al.
Published: (2023-02-01)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
by: Qianru Mei, et al.
Published: (2022-01-01)

Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis
by: Jan C. Kamp, et al.
Published: (2022-02-01)

Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice
by: Yicheng He, et al.
Published: (2021-10-01)

Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis
by: Dimitrios Kalafatis, et al.
Published: (2021-12-01)

Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype
by: Emily Fraser, et al.
Published: (2021-03-01)

Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3
by: Qingfang Li, et al.
Published: (2022-10-01)

Immunomodulatory effects of exosomes from different resources on idiopathic pulmonary fibrosis
by: Wu Jiamin, Zhang Wei, Zhang Xing, Chen Qi
Published: (2022-05-01)

Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01)

RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway
by: Fiorella Calabrese, et al.
Published: (2022-03-01)

Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
by: Prathibha R. Gajjala, et al.
Published: (2023-02-01)

Towards a better diagnosis of idiopathic pulmonary fibrosis
by: D. Valeyre
Published: (2011-06-01)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
by: Esteban Cano-Jiménez, et al.
Published: (2018-08-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
by: Mervi Kreus, et al.
Published: (2022-08-01)

The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophages
by: Takashi Matsuhira, et al.
Published: (2021-12-01)

Divergent roles of the Hippo pathway in the pathogenesis of idiopathic pulmonary fibrosis: tissue homeostasis and fibrosis
by: Ryusuke Kizawa, et al.
Published: (2023-09-01)

miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach
by: Jovito Cesar Santos-Álvarez, et al.
Published: (2022-03-01)

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
by: Cao X, et al.
Published: (2021-02-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01)

Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis
by: Yong Mou, et al.
Published: (2022-05-01)

Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014
by: Eduardo Algranti, et al.

Erythropoietin: role in idiopathic pulmonary fibrosis revisited
by: Contributors A.O Abdel-Aziz, et al.
Published: (2020-01-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro
by: Juan Manuel Velázquez-Enríquez, et al.
Published: (2021-08-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
by: Hamza M Al‐Tamari, et al.
Published: (2018-02-01)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
by: Wei-An Chang, et al.
Published: (2020-11-01)